Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACSPI 2 patient-controlled sedation for port implantation
2021-003821-31Phase 4Completed
- Sponsor
- Region Jönköpings Län
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of propofol and alfentanil (2 arms), sponsored by Region Jönköpings Län. Primary endpoint: Patient-reported pain perception. Started Jan 2022; status: completed.
02
Drugs
propofolalfentanil
Beyond the preview
Go deeper on 2021-003821-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003821-31.